Please enable JavaScript.
Coggle requires JavaScript to display documents.
RESISTENCIA ANTIMICROBIANA EN EL PERÚ, image - Coggle Diagram
RESISTENCIA ANTIMICROBIANA EN EL PERÚ
Escherichia coli
2007
Trimetoprim/Sulfametoxazol (71.2%)
Quinolonas (55%)
Cefalosporinas (35%)
2009
Ampicilina (>80%)
Ácido nalidixico y ciprofloxacina (>60%)
2023
Cefalosporinas 3G (62.5%)
Quinolas (61.8%)
Neisseria gonorrhoeae
2017
Tetraciclina (54.2%)
Penincilina (51%)
Ciprofloxacino (82.3%)
Staphylococcus aureus
2007
Eritromicina (73.1%)
Gentamicina (67.4%)
Oxacilina (71.7%)
2012
Penicilina (99%)
Eritromicina (80%)
Meticilina (84%)
Clindamicina (75%)
Klebsiella pneumoniae
2007
Cefalosporinas 3G (67%)
Aminoglicosidos (67.8%)
2012
Cefalosporinas 3G y 4G (50%)
2023
Cefalosporina 3G (69.2%)
Carbapenémicos (7.7%)
Streptococcus pneumoniae
2000-2010
Pacientes sin meningitis - penicilina (12.9%)
Eritromicina (13%)
Pacientes con meningitis - penicilina (46.2%)
2011-2016
Eritromicina (71.6%)
Pseudomonas aeruginosa
2007
Ceftazidima (53.6%)
Gentamicina (54.9%)
2012
Todas las familias (30%)
